Author:
Kaleita T. A.,Tubergen D. G.,Stehbens J. A.,MacLean W. E.,Noll R. B.,Cherlow J. M.,Cantor N. L.,Chang P. N.,O’Brien R. T.,Ruymann F. B.,Sather H. N.,Schwartz E.,Whitt J. K.,Waskerwitz M. J.,Hammond G. D.
Publisher
Springer Berlin Heidelberg
Reference50 articles.
1. Henze G., Langermann H.J., Bramswig J., Breu H., Gadner H., Schellong G., Welte K., Riehm H. (1981). Ergebnisse der Studie BFM 76/79 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen. Klin Pädiat 193: 145–154.
2. Riehm H., Gadner H., Henze G., Kornhuber B., Lampert F., Niethammer D., Reiter A., Schellong G. (1990). Results and significance of six randomized trials in four consecutive ALL-BFM trials. In Buchner T., Schellong G., Hiddemann W., Ritter J. (eds) Haematology and Blood Transfusion. Berlin, Springer-Verlag: 33: 439–450.
3. Tubergen D.G., Gilchrist G.S., O’Brien R.T., Coccia P.F., Sather H.N., Waskerwitz M.J., Hammond G.D. (1993). Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: A Children Cancer Group Phase III Trial. J Clin Oncol 11:527–537.
4. Tubergen D.G., Gilchrist G.S., O’Brien R.T., Coccia P.F., Sather H.N., Waskerwitz M.J., Hammond G.D. (1993). Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparis o n of cranial radiation and intrathecal methotrexate and the importance of systemic therapy. A childrens Cancer Group report. J Clin Oncol 11: 520–526.
5. Stehbens J.A., Kaleita T.A., Noll R.B., MacLean W.E., O’Brien R.T., Waskerwitz M.J., Hammond G.D. (1991). CNS prophylaxis of childhood leukemia: What are the long-term neurological, neuropsychological and behavioral effects? Neuropsych Rev 2: 147–177.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献